List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 17 studies with search of: Open Studies | "Thymus Neoplasms"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
Condition: Locally Advanced Stage III or IV Thymic Cancer
Intervention: Drug: neoadjuvant docetaxel/cisplatin
2 Recruiting Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
Conditions: Non Small Cell Lung Cancer;   Small Cell Lung Cancer;   Thymoma;   Thymus Neoplasms
Intervention: Radiation: Esophageal sparing IMRT
3 Recruiting Hypofractionated Proton Radiation Therapy
Conditions: Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Carcinoid;   Thymic Cancer;   Lung Cancer
Intervention: Radiation: Proton Therapy
4 Recruiting Molecular Analysis of Thoracic Malignancies
Conditions: Thymus Cancer;   Thymoma;   Thymic Carcinoma;   Lung Cancer;   Carcinoma, Non-Small-Cell Lung;   Mesothelioma
Intervention:
5 Recruiting A Phase II Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Conditions: Thymoma;   Thymus Cancer;   Thymic Carcinoma
Intervention: Drug: Amrubicin
6 Recruiting Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Conditions: Pleural Metastases;   Breast Cancer;   Colon Cancer;   Ovarian Cancer;   Uterine Cancer;   Renal Cell Cancer;   Thymic Cancer
Intervention: Procedure: Surgical debulking and Intrathoracic Hyperthermic Chemotherapy
7 Recruiting Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Conditions: Lung Cancer;   Esophageal Cancer;   Malignant Pleural Mesothelioma;   Thymoma;   Thymic Carcinoma
Interventions: Biological: Allogeneic Tumor Cell Vaccine (K562);   Drug: Celecoxib;   Drug: cyclophosphamide
8 Recruiting Paclitaxel and Cisplatin for Thymic Neoplasm
Conditions: Thymoma;   Thymic Carcinoma
Intervention: Drug: paclitaxel and cisplatin
9 Recruiting A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies
Conditions: Thymoma;   Thymic Carcinoma
Interventions: Drug: Belinostat;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Doxorubicin
10 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
11 Recruiting Nonmyeloablative Allogeneic Transplant
Conditions: Aplastic Anemia;   Paroxysmal Nocturnal Hemoglobinuria;   Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplastic Syndrome;   Chronic Myelogenous Leukemia;   Chronic Lymphocytic Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Mantle Cell Lymphoma;   Multiple Myeloma;   Waldenstrom Macroglobulinemia;   Breast Cancer;   Renal Cell Carcinoma;   Melanoma;   Sarcoma;   Ovarian Cancer;   Thymoma
Intervention: Procedure: Nonmyeloablative Allogeneic Transplant
12 Recruiting Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Condition: Thymic Carcinoma
Intervention: Drug: PHA-848125AC
13 Recruiting Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Conditions: Thymoma;   Thymic Carcinoma;   Thymic Carcinoid;   Thymic Neuroendocrine Tumors
Intervention: Drug: IMA12
14 Recruiting Preoperative Treatment of Patients With High Risk Thymoma
Condition: Thymoma
Interventions: Drug: cisplatin and etoposide;   Procedure: Surgical Resection;   Radiation: Concurrent Radiotherapy
15 Recruiting Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
Conditions: Malignancy;   Cancer;   Non Small Cell Lung Cancer;   Small Cell Lung Cancer;   Testicular Cancer;   Thymoma;   Ovarian Cancer;   Osteosarcoma
Intervention: Drug: palifosfamide-tris
16 Recruiting Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma
Conditions: Thymoma;   Clinical Masaoka Stage II-IVA
Intervention: Drug: Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
17 Recruiting Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Condition: Malignant Thymoma
Intervention: Drug: PHA-848125AC

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services